Format
Sort by
Items per page

Send to

Choose Destination

Best matches for nail dystrophy OR nail pitting OR alopecia areata:

Overview of alopecia areata. Hordinsky MK et al. J Investig Dermatol Symp Proc. (2013)

Alopecia areata: an evidence-based treatment update. Hordinsky M et al. Am J Clin Dermatol. (2014)

Emerging treatments in alopecia. Falto-Aizpurua L et al. Expert Opin Emerg Drugs. (2014)

Search results

Items: 1 to 20 of 4854

1.

Case of alopecia induced by sorafenib, possible mechanism similar to alopecia areata.

Tanaka Y, Sugawara K, Shimizu N, Mizukami Y, Tsuruta D.

J Dermatol. 2017 Nov 15. doi: 10.1111/1346-8138.14125. [Epub ahead of print] No abstract available.

PMID:
29139143
2.

Recessive Mutation in Tetraspanin CD151 Causes Kindler Syndrome-like Epidermolysis Bullosa with Multi-systemic Manifestations Including Nephropathy.

Vahidnezhad H, Youssefian L, Saeidian AH, Mahmoudi HR, Touati A, Abiri M, Kajbafzadeh AM, Aristodemou S, Liu L, McGrath JA, Ertel A, Londin E, Kariminejad A, Zeinali S, Fortina P, Uitto J.

Matrix Biol. 2017 Nov 11. pii: S0945-053X(17)30243-3. doi: 10.1016/j.matbio.2017.11.003. [Epub ahead of print]

PMID:
29138120
3.

Unilesional Follicular Mycosis Fungoides: Report of 6 Cases and Review of the Literature.

Magro CM, Telang GH, Momtahen S.

Am J Dermatopathol. 2017 Oct 24. doi: 10.1097/DAD.0000000000000997. [Epub ahead of print]

PMID:
29135509
4.

The water-drop test for the diagnosis of koilonychia.

Chelidze K, Lipner SR.

J Am Acad Dermatol. 2017 Dec;77(6):e157-e158. doi: 10.1016/j.jaad.2017.06.034. No abstract available.

PMID:
29132861
5.

Willingness to pay and quality of life in alopecia areata.

Okhovat JP, Grogan T, Duan L, Goh C.

J Am Acad Dermatol. 2017 Dec;77(6):1183-1184. doi: 10.1016/j.jaad.2017.07.023. No abstract available.

PMID:
29132855
6.

Objective Outcome Measures: Collecting Meaningful Data on Alopecia Areata.

Olsen EA, Roberts J, Sperling L, Tosti A, Shapiro J, McMichael A, Bergfeld W, Callender V, Mirmirani P, Washenik K, Whiting D, Cotsarelis G, Hordinsky M.

J Am Acad Dermatol. 2017 Nov 8. pii: S0190-9622(17)32614-2. doi: 10.1016/j.jaad.2017.10.048. [Epub ahead of print]

PMID:
29128463
7.

Successful treatment of moderate-to-severe alopecia areata improves health-related quality of life.

Liu LY, Craiglow BG, King BA.

J Am Acad Dermatol. 2017 Nov 8. pii: S0190-9622(17)32607-5. doi: 10.1016/j.jaad.2017.10.046. [Epub ahead of print] No abstract available.

PMID:
29128459
8.

Janus kinase inhibitors for the use of alopecia areata: A promising therapeutic of the future.

Updyke KM.

Dermatol Ther. 2017 Nov 10. doi: 10.1111/dth.12556. [Epub ahead of print] No abstract available.

PMID:
29124830
9.

Utilization of Mental Health Resources and Complementary and Alternative Therapies for Alopecia Areata: A U.S. Survey.

Hussain ST, Mostaghimi A, Barr PJ, Brown JR, Joyce C, Huang KP.

Int J Trichology. 2017 Oct-Dec;9(4):160-164. doi: 10.4103/ijt.ijt_53_17.

10.

Detection of Tumor Necrosis Factor-alpha in Nonlesional Tissues of Alopecia Areata Patients: A Prove for a Systemic Disease.

Gohary YM, Abdel Fattah DS.

Int J Trichology. 2017 Oct-Dec;9(4):154-159. doi: 10.4103/ijt.ijt_47_17.

11.

Insignificant Correlation between Thyroid Hormone and Antithyroid Peroxidase Antibodies in Alopecia Areata Patients in Northern Rajasthan.

Kaur G, Kuldeep CM, Bhargava P, Mathur DK, Sharda S, Chaturvedi P.

Int J Trichology. 2017 Oct-Dec;9(4):149-153. doi: 10.4103/ijt.ijt_32_17.

12.

Tofacitinib 2% ointment, a topical janus kinase inhibitor, for the treatment of alopecia areata: a pilot study of 10 patients.

Liu LY, Craiglow BG, King BA.

J Am Acad Dermatol. 2017 Nov 3. pii: S0190-9622(17)32601-4. doi: 10.1016/j.jaad.2017.10.043. [Epub ahead of print] No abstract available.

PMID:
29108908
13.

Subclinical Sensitization with Diphenylcyclopropenone is Sufficient for the Treatment of Alopecia Areata: Retrospective Analysis of 159 Cases.

Choe SJ, Lee S, Pi LQ, Keum DI, Lee CH, Kim BJ, Lee WS.

J Am Acad Dermatol. 2017 Nov 3. pii: S0190-9622(17)32600-2. doi: 10.1016/j.jaad.2017.10.042. [Epub ahead of print]

PMID:
29108907
14.

Clinicopathologic features of 28 cases of nail matrix nevi (NMNs) in Asians: Comparison between children and adults.

Lee JH, Lim Y, Park JH, Lee JH, Jang KT, Kwon EJ, Lee DY.

J Am Acad Dermatol. 2017 Oct 26. pii: S0190-9622(17)32317-4. doi: 10.1016/j.jaad.2017.08.052. [Epub ahead of print]

PMID:
29107341
15.

Pediatric severity of alopecia tool.

Bernardis E, Nukpezah J, Li P, Christensen T, Castelo-Soccio L.

Pediatr Dermatol. 2017 Nov 6. doi: 10.1111/pde.13327. [Epub ahead of print]

PMID:
29105836
16.

An Overview of the Biology of Platelet-Rich Plasma and Microneedling as Potential Treatments for Alopecia Areata.

Strazzulla LC, Avila L, Lo Sicco K, Shapiro J.

J Invest Dermatol. 2017 Nov 3. pii: S0022-202X(17)32751-3. doi: 10.1016/j.jid.2017.07.827. [Epub ahead of print] Review.

PMID:
29103820
17.

Ibrutinib-Associated Nail Plate Abnormalities: Case Reports and Review.

Heldt Manica LA, Cohen PR.

Drug Saf Case Rep. 2017 Nov 1;4(1):15. doi: 10.1007/s40800-017-0060-1.

18.

Alopecia Areata. Current situation and perspectives.

Juárez-Rendón KJ, Rivera Sánchez G, Reyes-López MÁ, García-Ortiz JE, Bocanegra-García V, Guardiola-Avila I, Altamirano-García ML.

Arch Argent Pediatr. 2017 Dec 1;115(6):e404-e411. doi: 10.5546/aap.2017.eng.e404. English, Spanish.

19.

Syphilitic alopecia: uncommon trichoscopic findings.

Tognetti L, Cinotti E, Perrot JL, Campoli M, Rubegni P.

Dermatol Pract Concept. 2017 Jul 31;7(3):55-59. doi: 10.5826/dpc.0703a12. eCollection 2017 Jul.

20.

Alopecia areata is characterized by expansion of circulating Th2/Tc2/Th22, within the skin-homing and systemic T-cell populations.

Czarnowicki T, He HY, Wen HC, Hashim PW, Nia JK, Malik K, Estrada Y, Kimmel GW, Taliercio M, Krueger JG, Guttman-Yassky E.

Allergy. 2017 Oct 30. doi: 10.1111/all.13346. [Epub ahead of print]

PMID:
29083474

Supplemental Content

Loading ...
Support Center